Latest California Healthline Stories
Racial Disparities in Lung Cancer Start With Research
Improving lung cancer outcomes in Black communities will take more than lowering the screening age, experts say. Disparities are present in everything from the studies that inform when people should get checked to the availability of care in rural areas.
Readers and Tweeters Decry Medical Billing Errors, Price-Gouging, and Barriers to Benefits
KHN gives readers a chance to comment on a recent batch of stories.
Despite Katie Couric’s Advice, Doctors Say Ultrasound Breast Exams May Not Be Needed
When Katie Couric announced she had breast cancer, she urged women to get a mammogram — and, if they have dense breasts, to get supplemental screening by ultrasound. But medical experts point out that ultrasound and other auxiliary screenings haven’t been proven to do more than regular mammography in reducing mortality.
$38,398 for a Single Shot of a Very Old Cancer Drug
Lupron, a drug patented half a century ago, treats advanced prostate cancer. It’s sold to physicians for $260 in the U.K. and administered at no charge. Why are U.S. hospitals — which may pay nearly as little for the drug — charging so much more to administer it?
Reporter Follows Up on ‘Cancer Moonshot’ Progress and the Bias in Digital Health Records
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Genetic Tests Create Treatment Opportunities and Confusion for Breast Cancer Patients
Doctors are divided on whether blanket testing of breast cancer patients is warranted, since scientists and physicians are sometimes unsure about how to interpret the results.
La última década ha sido testigo de una rápida expansión de las pruebas genéticas. Pero, ¿cuál es su real relevancia clínica?
New Abortion Laws Jeopardize Cancer Treatment for Pregnant Patients
As abortion restrictions take effect across the South in the wake of the Supreme Court’s decision to overturn Roe v. Wade, cancer doctors are trying to decipher the laws. They’re grappling with how to discuss options with pregnant patients, who may be forced to choose whether to proceed or forgo lifesaving cancer treatments that can prove toxic for the fetus.
Many Preventive Medical Services Cost Patients Nothing. Will a Texas Court Decision Change That?
A federal judge in Texas issued a decision this week that affects the Affordable Care Act. It says one way that preventive services are selected for no-cost coverage is unconstitutional.
Rural Americans Have Difficulty Accessing a Promising Cancer Treatment
Chimeric antigen receptor T-cell therapy has eliminated tumors in some late-stage cancer patients, but the cost and complexity of care mean rural Americans have trouble accessing the treatment.